BCG vaccination induces cross-protective immunity against pathogenic microorganisms

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Bacillus Calmette-Guérin (BCG) is an attenuated Mycobacterium bovis strain used to prevent Mycobacterium tuberculosis (M. tb) infection.
• BCG vaccination is known to potentiate immune responses to other vaccines and exert nonspecific immunomodulatory effects.
• These effects are linked to trained immunity, involving epigenetic reprogramming and metabolic shifts in innate immune cells.

Purpose of the Study:

• To explain the importance of BCG immunization.
• To elucidate the mechanisms of trained immunity induced by BCG.
• To explore the potential of BCG-induced trained immunity for rapid immune activation against unrelated pathogens.

Main Methods:

• Review of existing literature on BCG vaccination and trained immunity.
• Analysis of immunological and molecular mechanisms underlying BCG's effects.
• Discussion of clinical implications and future research directions.

Main Results:

• BCG vaccination induces trained immunity, characterized by epigenetic and metabolic changes in innate immune cells.
• Trained immunity contributes to BCG's protective effects against pathogens other than M. tb.
• BCG-induced trained immunity offers a potential strategy for broad-spectrum immune enhancement.

Conclusions:

• BCG immunization is crucial not only for tuberculosis prevention but also for its broader immunomodulatory effects.
• Trained immunity is a key mechanism explaining BCG's nonspecific protective capabilities.
• Harnessing BCG-induced trained immunity could lead to novel strategies for combating infectious diseases.